Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss

An oral drug from Pfizer (PFE) led to faster weight loss than weekly injections of Novo Nordisk's (NVO) diabetes blockbuster Ozempic, according to a paper released Monday. In response, Pfizer stock jumped.